126 related articles for article (PubMed ID: 8201380)
1. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
Rohatiner AZ; Johnson PW; Price CG; Arnott SJ; Amess JA; Norton AJ; Dorey E; Adams K; Whelan JS; Matthews J
J Clin Oncol; 1994 Jun; 12(6):1177-84. PubMed ID: 8201380
[TBL] [Abstract][Full Text] [Related]
2. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
[TBL] [Abstract][Full Text] [Related]
3. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.
Rohatiner AZ; Freedman A; Nadler L; Lim J; Lister TA
Ann Oncol; 1994; 5 Suppl 2():143-6. PubMed ID: 8204513
[TBL] [Abstract][Full Text] [Related]
4. Myeloablative therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma.
Rohatiner AZ; Price CG; Arnott S; Norton A; Evans ML; Cotter F; Dorey E; Davis CL; Clark P; Sterlini J
Ann Oncol; 1991 Feb; 2 Suppl 2():147-50. PubMed ID: 2049312
[TBL] [Abstract][Full Text] [Related]
5. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma.
Apostolidis J; Foran JM; Johnson PW; Norton A; Amess J; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
J Clin Oncol; 1999 Jan; 17(1):216-21. PubMed ID: 10458236
[TBL] [Abstract][Full Text] [Related]
6. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
Johnson PW; Price CG; Smith T; Cotter FE; Meerabux J; Rohatiner AZ; Young BD; Lister TA
J Clin Oncol; 1994 Apr; 12(4):798-805. PubMed ID: 8151322
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
Brown JR; Feng Y; Gribben JG; Neuberg D; Fisher DC; Mauch P; Nadler LM; Freedman AS
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1057-65. PubMed ID: 17697968
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
Apostolidis J; Gupta RK; Grenzelias D; Johnson PW; Pappa VI; Summers KE; Salam A; Adams K; Norton AJ; Amess JA; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
J Clin Oncol; 2000 Feb; 18(3):527-36. PubMed ID: 10653868
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
[TBL] [Abstract][Full Text] [Related]
10. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
Freedman AS; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Fisher DC; Schlossman R; Alyea EP; Takvorian T; Jallow H; Kuhlman C; Ritz J; Nadler LM; Gribben JG
Blood; 1999 Nov; 94(10):3325-33. PubMed ID: 10552941
[TBL] [Abstract][Full Text] [Related]
12. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.
Bonetti F; Zecca M; Pession A; Messina C; Montagna D; Lanino E; Fagioli F; Santoro N; Prete A; Cesaro S; Rondelli R; Giorgiani G; De Stefano P; Locatelli F
J Clin Oncol; 1999 Dec; 17(12):3729-35. PubMed ID: 10577844
[TBL] [Abstract][Full Text] [Related]
13. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients.
Colombat P; Donadio D; Fouillard L; Milpied N; Tilly H; Pico J; Abgrall JF; Coiffier B; Herbrecht R; Philip T
Bone Marrow Transplant; 1994 Feb; 13(2):157-62. PubMed ID: 8205084
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
Freedman AS; Takvorian T; Neuberg D; Mauch P; Rabinowe SN; Anderson KC; Soiffer RJ; Spector N; Grossbard M; Robertson MJ
J Clin Oncol; 1993 May; 11(5):931-6. PubMed ID: 8487057
[TBL] [Abstract][Full Text] [Related]
15. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ
Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
[TBL] [Abstract][Full Text] [Related]
16. Myeloablative therapy for follicular lymphoma.
Rohatiner AZ; Lister TA
Hematol Oncol Clin North Am; 1991 Oct; 5(5):1003-12. PubMed ID: 1938753
[TBL] [Abstract][Full Text] [Related]
17. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
[TBL] [Abstract][Full Text] [Related]
20. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]